Shengyang Wu

786 total citations
31 papers, 466 citations indexed

About

Shengyang Wu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Plant Science. According to data from OpenAlex, Shengyang Wu has authored 31 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 8 papers in Plant Science. Recurrent topics in Shengyang Wu's work include Antifungal resistance and susceptibility (4 papers), Head and Neck Cancer Studies (4 papers) and Plant Stress Responses and Tolerance (3 papers). Shengyang Wu is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Head and Neck Cancer Studies (4 papers) and Plant Stress Responses and Tolerance (3 papers). Shengyang Wu collaborates with scholars based in United States, China and Taiwan. Shengyang Wu's co-authors include Betty A. Wu‐Hsieh, Chih‐Pin Chuu, Jr‐Shiuan Lin, Gordon D. Brown, Ching‐Yu Lin, Li‐Yin Hung, Wenyu Chen, Ching‐Liang Chu, Kenneth S. Hu and Babak Givi and has published in prestigious journals such as Journal of Clinical Oncology, The Plant Cell and New Phytologist.

In The Last Decade

Shengyang Wu

31 papers receiving 462 citations

Peers

Shengyang Wu
Daniel Clarke Australia
Emma Jaeger United Kingdom
Jordan M. Meyers United States
K LEE South Korea
Dan-Paul Hartmann United States
Daniel Clarke Australia
Shengyang Wu
Citations per year, relative to Shengyang Wu Shengyang Wu (= 1×) peers Daniel Clarke

Countries citing papers authored by Shengyang Wu

Since Specialization
Citations

This map shows the geographic impact of Shengyang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyang Wu more than expected).

Fields of papers citing papers by Shengyang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyang Wu. The network helps show where Shengyang Wu may publish in the future.

Co-authorship network of co-authors of Shengyang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyang Wu. A scholar is included among the top collaborators of Shengyang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyang Wu. Shengyang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Xue, Shengyang Wu, Yumeng Zhang, et al.. (2025). OsSPL9 promotes Cu uptake and translocation in rice grown in high‐Fe red soil. New Phytologist. 246(5). 2207–2221. 1 indexed citations
2.
Wu, Shengyang, et al.. (2024). Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. Communications Biology. 7(1). 843–843. 5 indexed citations
3.
Jia, Bowei, Shengyang Wu, Tong Wu, et al.. (2023). A Glycine soja S1 group bZIP transcription factor GsbZIP43 is a positive regulator of sodium bicarbonate stress tolerance. Environmental and Experimental Botany. 217. 105551–105551. 2 indexed citations
4.
Katz, Leah, Victor Ng, Shengyang Wu, et al.. (2022). Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience. Frontiers in Oncology. 12. 870143–870143. 2 indexed citations
5.
Nguy, Susanna, Shengyang Wu, Cheongeun Oh, & Naamit K. Gerber. (2021). Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy. Breast Cancer Research and Treatment. 187(3). 815–830. 1 indexed citations
7.
Oh, Cheongeun, et al.. (2020). Radiation Dose Reduction in Early-Stage Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 20(12). 820–829. 2 indexed citations
8.
Wu, Shengyang & Betty A. Wu‐Hsieh. (2020). Neutrophil Extracellular Trap Killing Assay of Candida albicans. BIO-PROTOCOL. 10(16). e3716–e3716. 2 indexed citations
9.
Chang, Chia-Chieh, Ting‐An Lin, Shengyang Wu, Chun‐Pin Lin, & Hao‐Hueng Chang. (2020). Regeneration of Tooth with Allogenous, Autoclaved Treated Dentin Matrix with Dental Pulpal Stem Cells: An In Vivo Study. Journal of Endodontics. 46(9). 1256–1264. 30 indexed citations
10.
Wu, Shengyang, Pinghui Zhu, Bowei Jia, et al.. (2018). A Glycine soja group S2 bZIP transcription factor GsbZIP67 conferred bicarbonate alkaline tolerance in Medicago sativa. BMC Plant Biology. 18(1). 234–234. 24 indexed citations
11.
Zhang, Hang, Yuanming Liu, Chao Chen, et al.. (2018). Identification of novel interactors and potential phosphorylation substrates of GsSnRK1 from wild soybean (Glycine soja). Plant Cell & Environment. 42(1). 145–157. 31 indexed citations
12.
Liu, Chuyu, Shengyang Wu, Wenyu Chen, et al.. (2018). NLRX1 Facilitates Histoplasma capsulatum-Induced LC3-Associated Phagocytosis for Cytokine Production in Macrophages. Frontiers in Immunology. 9. 2761–2761. 39 indexed citations
13.
Chen, Wenyu, et al.. (2018). Human dendritic cell-specific ICAM-3-grabbing non-integrin downstream signaling alleviates renal fibrosis via Raf-1 activation in systemic candidiasis. Cellular and Molecular Immunology. 16(3). 288–301. 8 indexed citations
14.
Tam, Moses, Shengyang Wu, Naamit K. Gerber, et al.. (2018). The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers. The Laryngoscope. 128(10). 2326–2332. 34 indexed citations
15.
Wu, Shengyang, Benjamin T. Cooper, Christopher Bowman, et al.. (2017). A DNA methylation-based classifier for accurate molecular diagnosis of bone sarcomas.. Journal of Clinical Oncology. 35(15_suppl). 11034–11034. 2 indexed citations
16.
Wu, Shengyang, et al.. (2017). Spatial and Dosimetric Comparison of Tandem/Ring Applicator Against Adjustable Tandem/Ovoid and Tandem/Split-Ring for Intracavitary Brachytherapy Treatment of Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). E312–E312. 1 indexed citations
17.
Kwok, Mary, Shengyang Wu, Clifton C. Mo, Thomas A. Summers, & Mark Roschewski. (2016). Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas. Current Treatment Options in Oncology. 17(9). 47–47. 21 indexed citations
18.
Wu, Shengyang, et al.. (2016). The Effect of Breast Irradiation on Cardiac Disease in Women Enrolled on BCIRG-001 at 10-Year Follow-up. International Journal of Radiation Oncology*Biology*Physics. 96(2). S206–S206. 1 indexed citations
19.
Lin, Ching‐Yu, Shengyang Wu, Wenyu Chen, et al.. (2015). CR3 and Dectin-1 Collaborate in Macrophage Cytokine Response through Association on Lipid Rafts and Activation of Syk-JNK-AP-1 Pathway. PLoS Pathogens. 11(7). e1004985–e1004985. 76 indexed citations
20.
Wu, Shengyang, Yurong Xie, Yulong Ren, et al.. (2015). VLN2Regulates Plant Architecture by Affecting Microfilament Dynamics and Polar Auxin Transport in Rice. The Plant Cell. 27(10). tpc.15.00581–tpc.15.00581. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026